Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Cilansetron improves quality of life of patients with diarrhea-predominant IBS

Nov. 24, 2004

New Roche study investigates response rates to HCV therapy in Latinos

Nov. 24, 2004

Poor bioavailability results for R-803 in phase I/II HCV study

Nov. 24, 2004

New GLP-2 derivatives and their use in gastrointestinal disorders

Nov. 24, 2004

New angiotensin II receptor agonists covered by Vicore patent

Nov. 24, 2004

Preclinical and clinical efficacy of dextofisopam reported for IBS and IBD

Nov. 23, 2004

HepeX-C development progresses

Nov. 22, 2004

Promising safety profile of a peginterferon/ribavirin/amantadine regimen in HIV/HCV coinfection

Nov. 22, 2004

New clinical data on the antiviral efficacy of entecavir in hepatitis B

Nov. 19, 2004

Good toxicity profile of single and multiple doses of TC-2403-12 in healthy volunteers

Nov. 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...